JNJ vs ZBH
By Alex · Tickerpine
Johnson & Johnson vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ZBH |
|---|---|---|
| Price | $263.81 | $98.56 |
| Market cap | $635.07B | $18.80B |
| P/E ratio | 40.0 | 23.0 |
| ROE | 20.02% | 6.41% |
| Profit margin | 16.20% | 9.48% |
| Revenue growth | 5.90% | 4.80% |
| Dividend yield | 2.03% | 0.97% |
| Beta | 0.21 | 0.48 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ZBH in plain English
- JNJ is the bigger company — about 33.8× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 23.0 vs 40.0).
- JNJ earns a higher return on equity (20% vs 6%).
- JNJ is growing revenue faster (6% vs 5%).
- JNJ has the higher dividend yield (2.03% vs 0.97%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.